Stopping exclusive breastfeeding at 2 months · healthy breastfeeding women with healthy term babies
Summary of findings table ‐ Breastfeeding support only probably leads to lower stopping exclusive breastfeeding at 2 months compared with usual care (moderate certainty).
2 findings from 1 review
Stopping breastfeeding (any) at 3‐4 months · healthy breastfeeding women with healthy term babies
Summary of findings table ‐ Breastfeeding support only probably leads to lower stopping breastfeeding (any) at 3‐4 months compared with usual care (moderate certainty).
1 finding from 1 review
Stopping breastfeeding (any) at 9 months ‐ not reported · healthy breastfeeding women with healthy term babies
Summary of findings table ‐ Breastfeeding support only may leads to lower stopping breastfeeding at 9 months compared with usual care (low certainty).
1 finding from 1 review
Fetal/neonatal/infant · the fetus/neonate/infant
Summary of findings table ‐ Repeat dose(s) of prenatal corticosteroid showed no clear difference in A1: Fetal or neonatal or infant death (< 1 year of age) – all… compared with single course (moderate certainty).
1 finding from 1 review
B3: Caesarean section – an all women · the woman
Summary of findings table ‐ Repeat dose(s) of prenatal corticosteroids showed no clear difference in B3: Caesarean section – an all women compared with single course (moderate certainty).
1 finding from 1 review
B4: Discontinuation of therapy due to maternal adverse effects – an all women · the woman
1 finding from 1 review
Corticosteroid related adverse events · the woman
1 finding from 1 review
Admission to the intensive care unit ‐ not reported · the woman
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Breastfeeding at hospital discharge ‐ not reported · the woman
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
C1: Total deaths (after randomisation) up to early childhood · the child
Summary of findings table ‐ Repeat dose(s) of prenatal corticosteroids showed no clear difference in C1: Total deaths (after randomisation) up to early childhood compared with single course (moderate certainty).
1 finding from 1 review
C2: Neurodevelopmental impairment at early childhood · the child
Summary of findings table ‐ Repeat dose(s) of prenatal corticosteroids showed no clear difference in C2: Neurodevelopmental impairment at early childhood compared with single course (high certainty).
1 finding from 1 review
C3: Survival free of neurodevelopmental impairment at early childhood · the child
Summary of findings table ‐ Repeat dose(s) of prenatal corticosteroids showed no clear difference in C3: Survival free of neurodevelopmental impairment at early childhood compared with single course (high certainty).
1 finding from 1 review
C4: Survival free of major neurodevelopmental impairment atearly childhood · the child
Summary of findings table ‐ Repeat dose(s) of prenatal corticosteroids showed no clear difference in C4: Survival free of major neurodevelopmental impairment atearly… compared with single course (moderate certainty).
1 finding from 1 review
D1: Total deaths (after randomisation) up to mid‐ to later childhood · the child
Summary of findings table ‐ Repeat dose(s) of prenatal corticosteroids showed no clear difference in D1: Total deaths (after randomisation) up to mid‐ to later childhood compared with single course (moderate certainty).
1 finding from 1 review
Respiratory distress syndrome · the fetus/neonate/infant
Summary of findings table ‐ Repeat dose(s) of prenatal corticosteroid leads to lower A5: Respiratory distress syndrome – all fetuses randomised compared with single course (high certainty).
1 finding from 1 review
D2: Neurocognitive impairment atmid‐ to later childhood · the child
Summary of findings table ‐ Repeat dose(s) of prenatal corticosteroids showed no clear difference in D2: Neurocognitive impairment atmid‐ to later childhood compared with single course (low certainty).
1 finding from 1 review
D3: Survival free of neurocognitive impairment atmid‐ to later childhood · the child
Summary of findings table ‐ Repeat dose(s) of prenatal corticosteroids showed no clear difference in D3: Survival free of neurocognitive impairment atmid‐ to later… compared with single course (moderate certainty).
1 finding from 1 review
D4: Survival free of major neurocognitive impairment atmid‐ to later childhood · the child
Summary of findings table ‐ Repeat dose(s) of prenatal corticosteroids showed no clear difference in D4: Survival free of major neurocognitive impairment atmid‐ to later… compared with single course (moderate certainty).
1 finding from 1 review
A7: Severe lung disease – all fetuses randomised · the fetus/neonate/infant
Summary of findings table ‐ Repeat dose(s) of prenatal corticosteroid probably leads to lower A7: Severe lung disease – all fetuses randomised compared with single course (moderate certainty).
1 finding from 1 review
Chronic lung disease · the fetus/neonate/infant
Summary of findings table ‐ Repeat dose(s) of prenatal corticosteroid showed no clear difference in A8: Chronic lung disease – all fetuses randomised compared with single course (high certainty).
1 finding from 1 review